Stratatech corporation has entered into an agreement to be acquired by Mallinckrodt Pharmaceuticals. Company operations will continue in Madison. Terms were not disclosed. (Aug2016)
ASTO CT, LLC, a startup company developing an equine CT scan, has been added to the database. (Jun2016)
LYNX BIOSCIENCES, a startup assay development company and the 2016 life sciences winner of the Governor's Business Plan contest, has been added to the database. (Jun2016)
Varigen Biosciences, a metagenomics startup company founded by David Mead, PhD and Mark Liles PhD, has been added to the database. (May2016)
Neuwave medical announced that it would be acquired by the Ethicon unit of Johnson and Johnson. The transaction is expected to close in Q2 2016. (Mar2016)
Monsanto announced its intention to close its Middleton based Agracetus plant genetics research site in early 2016, transferring the programs and half of the 40 local positions to St. Louis. (Oct2015)
Stratatech Corporation announced that it received a U.S. government contract valued at up to $247 million to support the development and commercialization of its flapship product, StrataGraft skin tissue, a therapy for severe burns that replaces the need for skin transplantation. (Oct2015)
Scilog, a unit of Parker Hannifin, has announced it will close its Madison operations and consolidate operations into other units. (Jul2015)
bluDiagnostics , winner of the 2015 Wisconsin Governor's Business Plan contest, has been added to the database. The company is developing a diagnostic device for infertility. (Jun2015)
Takeda has announced its intent to close its Madison vaccine R&D site as part of an company-wide reorganization intended to consolidate all vaccine R&D in Boston. Actual consolidation will occur over a two year period. (Jun2015)
Ikaria Holdings, a Seattle based company with a Madison medical device business unit, has been acquired by Mallinckrodt Pharmaceuticals. (Apr2015)
Xylome Corporation, an early stage company developing biofuels technologies, recently established an office in the MG&E Innovation Center,and has been added to the database. (Apr2015)
Cellular Dynamics International was acquired by Fujifilm Holdings of Japan for $307 million. They will continue to operate the company in Madison as a wholly owned subsidiary as part of their regenerative medicine portfolio. (May2015)
Innotech Materials, LLC, a start-up company pursuing biomass conversion technologies, has been added to the database. (Mar2015)
AmebaGone Inc., has been added to the database. Founded by Dr. Marcin Filutowicz, the firm is developing a natural approach to overcome antibiotic resistance. (Mar2015)
Conjugon changed its name to Atterx Biotherapeutics Inc. (Dec2014)
Neurosolis, Inc., a startup developing therapeutics for CNS disorders, has been added to the database. (Nov2014)
Hologic - Third Wave technologies has closed its Madison operations, as planned. (Sep 2014) becton Dickinson earlier in 2014 closed its Madison operations as well.
BioTechnique has acquired the former Mentor fill-finish facility and will initiate contract manufacturing services for sterile injectable products by early 2015. It anticipates eventually employing over 100 professionals. (Aug2014)
POintcare genomics corp., a startup developing a point-of-care diagnostic test for cardiac ischemia, has been added to the database (July2014).
Gammex/RMI was acquired by Sun Nuclear Corporation (July2014)
Elucent Medical, a medical device startup developing a diagnostic device for use in breast cancer surgery and winner of the 2014 Wisconsin Governor's Business Plan Contest, has been added to the database.
HealthMyne, a startup company developing medical imaging technology, has been added to the database.
Novelos Therapeutics was renamed Cellectar Biosciences, Inc. in Feb 2014.
Scientific protein labs agreed in Dec 2013 to be acquired by Shenzhen Hepalink Pharmaceutical Company for $337 million. Hepalink is a leading manufacturer of heparin based in China.
Semba Biosciences has relocated within the University Research Park from the MG&E Innovation Center to 601 Science Drive. (Jun 2015)
Takeda Vaccines (fka Inviragen) has relocated within Madison from Odana Road to the University Research Park at 504 S. Rosa Road.
Tasso Inc. has moved to 110 E. Main Street (Aug 2014)
nexcyon pharmaceuticals has relocated its headquarters to West Washington Ave Madison (Mar 2014)
Centrose LLC relocated from 902 to 918 Deming Way, Madison (Mar 2014)
Quintessence Biosciences relocated from the University Research Park to 3300 Commercial Avenue, Madison (Jan 2014)